Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
When initial therapy proves insufficient, treatment escalation includes: Biologic DMARDs targeting specific inflammatory pathways (TNF inhibitors, IL-6 inhibitors, T-cell costimulation blockers, B-cell depleting agents) Targeted synthetic DMARDs such as JAK inhibitors (tofacitinib, baricitinib, upadacitinib), which carry FDA boxed warnings for serious cardiovascular events, malignancy, and thrombosis [24] [25] Combination DMARD therapy Short-term glucocorticoids for symptom control during treatment initiation Before starting biologic or targeted synthetic DMARDs, screening for tuberculosis and hepatitis B is recommended, along with appropriate vaccinations according to ACR guidelines
As part of the deal, AstraZeneca is acquiring the exclusive rights to ECC5004, an investigational oral once-daily pill for treating obesity, type 2 diabetes and other cardiometabolic conditions
(2020) GLP-1 NotchLAG-1 CSL control of the germline stem cell fate is mediated by transcriptional targets lst-1 and sygl-1
Individuals with fibromyalgia frequently experience widespread pain, severe fatigue, sleep disruption, cognitive fog, and heightened sensory sensitivity
Glutathione protects the mitochondria from this internal oxidative stress
Learn more about cholesterol management in PCOS
US$ 27.23
US$ 24.30
US$ 29.64
